Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part B. Does nitric oxide influence the effect of secretin on isolated heart function?

Polish Journal of Pharmacology

Volumn 52, Issue 5, 2000, Pages 375-381

  Sitniewska, E M ^a   Wisniewska, R J ^a   Wisniewski, K ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Isolated heart; Nitric oxide; Rats; Secretin

Indexed keywords

AMINO ACID; ARGININE; CALCITONIN GENE RELATED PEPTIDE; ENZYME INHIBITOR; ETHER; G PROTEIN COUPLED RECEPTOR; GASTROINTESTINAL POLYPEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN; HORMONE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; OXYGEN; PEPTIDE HISTIDINE ISOLEUCINE; SECRETIN; SODIUM CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG ACTIVITY; ENZYME INHIBITION; HEART CONTRACTION; HEART FUNCTION; HEART RATE; HORMONE ACTION; INOTROPISM; ISOLATED HEART; MALE; NEGATIVE FEEDBACK; NONHUMAN; RAT;

ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEART; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RATS; RATS, WISTAR; SECRETIN;

EID: 0033676059     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ornithine decarboxylase activity is critical for cell transformation
2. The effect of secretin on peripheral arterial blood flow
3. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini
4. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
5. Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels
6. Species variations and physiopathology of VIP-PHI-secretin receptors in heart and lung
7. Multiple effects of nitroprusside on membrane currents in smooth muscle cells isolated from rabbit pulmonary artery
8. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture
9. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
10. Nitric oxide modulates vascular permeability in the rat coronary circulation
11. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility
12. Agmatine: A novel endogenous vasodilator substance
13. Effect of secretin on visceral hemodynamics and pancreatic function
14. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine
15. Nitric oxide as a mediator of inflammation
16. Secretin receptors in the neuroglioma hybrid cell line NG108-15
17. Stimulation of nitric oxide from muscle cells by VIP: Prejunctional enhancement of VIP release
18. Haemodynamic effects of pharmacological doses of secretin in patients with impaired left ventricle function
19. Cardiovascular effect of secretin infusion in man
20. Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs
21. Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-N(G)-nitro-arginine
22. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
23. Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes
24. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries
25. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells
26. Nitric oxide and cardiac function
27. Control of coronary vascular tone by nitric oxide
28. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans
29. Myocardial contractile response to nitric oxide and cGMP
30. Nitric oxide: Physiology, pathophysiology and pharmacology Pharmacol
31. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
32. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells
33. Regulation of biosynthesis of nitric oxide
34. Tissue specific expression of the rat secretin precursor gene
35. Secretin and portal blood flow
36. NO and cardiac diastolic function
37. Effects of natriuretic factor, sodium nitroprusside, and acetylocholine on cyclic GMP levels and relaxation in aorta
38. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
39. The new biology of gastrointestinal hormones
40. In vivo evidence of and endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats
41. Cardiovascular effects of secretin
42. Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine
43. 2+-independent nitric oxide synthase in the myocardium
44. Nitric oxide synthase in cultured endocardial cells of the pig
45. Cardiovascular action of secretin in intact rats versus rats with streptozotocin-induced diabetes mellitus
46. Coronary vasodilatory action of VIP
47. Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein-coupled receptors
48. Some statistical methods useful in circulation research
49. 2+-activated channels in vascular smooth muscle cells